ECT – Electro-Cancer-Therapy / Electro-Galvano-Therapy / Electro-Chemo-Therapy

Today, there are several ways to remove degenerated tissue. Established are surgery, radiation and chemotherapy. Other methods are:
Hyperthermia, laser, cryosurgery, or ECT (Electro Cancer Therapy) also called BET (Bio-Electro-Therapy), PET (Percutaneous Electro-Tumor Therapy) or Galvanotherapy.

The result of Treatments with ECT
The tumor tissue is destroyed without affecting surrounding healthy body cells. The sterile dead tissue (aseptic necrosis) slowly detaches from the healthy tissue in the following weeks and is either rejected (in the case of tumors lying on the surface) or metabolized by the body’s own scavenger cells (phagocytes). For some time now, not only needle electrodes have been used, but also flat electrodes for the treatment of internal organs, which can be applied to the abdomen and back, for example. One of the areas of application for ECT is therefore now also the treatment of prostate cancer, for example, in order to spare the patient an operation. Particularly in the case of a still very small tumor that is not accompanied by symptoms, patients often have problems deciding to undergo major surgery. BET/ECT can help here in a gentle way to avoid unnecessary major surgery.

The voltage generated between the electrodes during galvanic current leads to almost selective destruction of tumor tissue. It represents a new way to gently destroy tumor tissue.
The direct current flowing between two or more electrodes leads to tissue decomposition by means of electrolysis. The ion migration causes a significant pH shift in the tissue. An acidic pH or acidosis is produced at the anode, and an alkaline pH or alkalosis is produced at the cathode. The pH values reached are far outside the physiological range and are therefore damaging to tissue. The direct current also leads to a change in membrane potentials by altering the electrolyte environment around and within the cell. As a result, important physiological functions, such as the sodium-potassium pump, are most sensitively disturbed. In the electric field, various salts dissociate into cations and anions, so that the homeostasis of the cell is cancelled. In the tissue, vasodilatation occurs at the cathode and desiccation, pain relief and anti-inflammation at the anode. As a result, tumor tissue is devitalized. Electrical devitalization is not a common electrical injury. It is almost always painless and it does not disturb the general condition. Rejection of the electrically induced necrosis takes place only after weeks. The loss of substance corresponds in size to the original spread of tumor tissue.

ECT treatment is suitable for superficial and also deeper solid tumors or metastases. Depending on the size of the tumor, different numbers of electrodes are required. Current is transmitted to the tissue by platinum electrodes. The therapy can usually be performed under local anesthesia, since pain receptors are depolarized by the low direct current and the conductivity of the sensitive nerves is paralyzed by the acids and alkalis that occur.

ECT also induces an actively specific immune phenomenon, as tumor antigens are released by the galvanic current and presented to immune cells attracted by the current. Tissue destruction releases cytokines, leading to increased recognition of tumor antigens and promoting specific immune responses in the tumor carrier. ECT can be combined with radiation, hyperthermia, chemotherapy, immune and other complementary therapies.

Thanks to the pioneering work of Dr. Rudolf Pekar from Bad Ischl, Germany who has been refining the methodology of the Galvano method since the beginning of the 1970s, and to the publication of his experiences, as well as to Swedish, Austrian and US-American research work, it is now possible to successfully carry out tumor therapy with galvanic currents.

At present, Electro-Cancer-Therapy is successfully applied in Germany, Austria, Denmark, Italy and China. There are already clear signs of success. It should be emphasized that with percutaneous electro-tumor therapy, the danger of metastasis formation can be practically ruled out, as this is counteracted preventively. It concerns here complex electrical processes in the metabolism of the organism and/or the cells with strong effect on bioelectrical fields.

The therapy is particularly suitable for superficial or even deeper solid tumor types that are not operable for aesthetic and functional reasons. These include: Prostate carcinomas as also recently shown in a study at the University Clinic Frankfurt under the direction of Prof. Dr. med. Vogl. Other indications include breast carcinomas, especially recurrences after radiation and chemotherapy, selected tumors of the ear, nose and throat, skin carcinomas such as basaliomas, spinaliomas, melanomas, etc., skin metastases, soft tissue tumors, isolated organ metastases. Tumors are often located more or less superficially, for example in the area of: facial skull, glands, muscles, breast, lymph, arms, legs, skin and are thus accessible.

Domestic and foreign studies prove the positive effect of this tumor therapy – especially significant in China with up to 80% healing success.
Direct current therapy was already in use towards the end of the last century. However, this form of therapy has been forgotten due to the introduction of chemotherapy.

How direct current therapy works: By means of several electrically insulated special needles or surface electrodes, it is possible to build up a voltage field within a tumor by means of direct current, whereby a depolarization of the tumor cell membrane is achieved. The voltage field is maintained by selective administration of a given current intensity (milliampere/mA) in a given time.

Every cell has an electrical potential as an electrical process. Every biological event also has an electrical process.

Health and disease are therefore also related to electric currents, which also condition an electric field. The classical tumor therapies (surgery / chemotherapy / radiotherapy) eliminate the tumor if necessary, but the changed electromagnetic field is not corrected (theory of local recurrence). The remaining polarization and with it the transforming tendency of the area can form the bases for a relapse (metastases) and this explains why the curative measures only eliminate an effect, but leave the causation behind (Dr. Pekar, Austria). The application of direct electric current could reverse the polarity of the non-orderly electric field and thus induce the energetic flow of current according to the laws of the whole organism and thus self-healing and activate the immune system. Independently of each other, in Europe since the end of the 1960s, Dr. Nordenstroem (Sweden) and Dr. Pekar (Austria) have continued and developed direct current therapy for clinical use. The mechanisms of action of direct current therapy are not yet fully understood. However, some mechanisms of action at the cellular level have already been scientifically proven through research.
Direct current therapy is successfully applied in many countries (China, Brazil, Italy, Denmark, Sweden, Austria).

Legal notice:
We would like to point out that the methods and systems presented here, as well as their results and effects, are not currently recognized by orthodox medicine.

Study situation
Prof. Dr. Xin YU-LING in China treated tumor patients with direct current. He achieved complete remission in 28.3% of 593 patients with lung cancer, partial remission in 50.3%, no remission in 12.8%, and an increase in tumor size in 8.6%. In liver tumors, he achieved complete remission in 25.2% of the 389 liver cancer patients treated and partial remission in 50.4%. In this group of patients, there was no remission in 19.0% of cases and tumor enlargement in 5.1% of cases. Complete remission means that no tumor is detectable after treatment. Partial remission refers to a reduction of the tumor by more than half of its initial size. No remission means that the tumor has only shrunk by up to 30% of its initial size. Xin also lists the survival times of patients treated with direct current therapy. All patients with a small tumor (3-5 cm in diameter) at the start of therapy were still alive one year after the end of therapy. After five years, 70% of these patients were still alive. In patients with locally limited tumors (stage T1N0M0 according to the TNM classification of the WHO), the 1-year survival time was 100% – and the 5-year survival time 85%. Why this therapy is not widely used in Germany remains an absolute mystery to me personally to this day.

The content presented here is for neutral information and general education purposes only. They do not constitute a recommendation or advertisement of the diagnostic methods, treatments or drugs described or mentioned. The text does not claim to be complete, nor can the timeliness, accuracy and balance of the information presented be guaranteed. The text is in no way a substitute for professional advice from a physician or pharmacist, and it should not be used as a basis for independent diagnosis and initiation, modification or termination of treatment of any disease. Always consult the physician or alternative practitioner of your confidence in case of health questions or complaints! We assume no liability for any inconvenience or damage resulting from the use of the information presented here.

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.